GAP-43 (growth-associated protein-43) is a dually palmitoylated protein, at cysteine residues at positions 3 and 4, that mostly localizes in plasma membrane both in neural and non-neural cells. In the present study, we have examined membrane association, subcellular distribution and intracellular trafficking of GAP-43 in CHO (Chinese hamster ovary)-K1 cells. Using biochemical assays and confocal and video microscopy in living cells we demonstrated that GAP-43, at steady state, localizes at the recycling endosome in addition to the cytoplasmic leaflet of the plasma membrane and TGN (trans-Golgi network). Pharmacological inhibition of newly synthesized GAP-43 acylation or double mutation of Cys 3 and Cys 4 of GAP-43 completely disrupts TGN, plasma membrane and recycling endosome association. A combination of selective photobleaching techniques and timelapse fluorescence microscopy reveals a dynamic association of GAP-43 with recycling endosomes in equilibrium with the plasma membrane pool. Newly synthesized GAP-43 is found mainly associated with the TGN, but not with the pericentriolar recycling endosome, and traffics to the plasma membrane by a brefeldin A-insensitive pathway. Impairment of plasma membrane fusion and internalization by treatment with tannic acid does affect the trafficking of GAP-43 from plasma membrane to recycling endosomes which reveals a vesicle-mediated retrograde trafficking of GAP-43. Here, we also show that internalization of GAP-43 is regulated by Arf (ADP-ribosylation factor) 6. Taken together, these results demonstrate that dual acylation is required for sorting of peripheral membrane-associated GAP-43 to recycling endosome via an Arf6-associated endocytic vesicular pathway.
INTRODUCTION
S-acylated peripheral proteins such as the small G-proteins Ras, Gα subunit, and also the neuronal proteins post-synaptic density protein-95 and GAP-43 (growth-associated protein-43) [1] are synthesized in the cytosol and then post-translationally modified by different lipid moieties [2] . The subcellular distribution of these acylated proteins, which occur by vesicular transport or reversible membrane association, depends on the number and types of lipids attached, on the physicochemical properties of aa (amino acids) surrounding the lipidation site, as well as on the presence of additional domains (i.e. protein-protein and proteinlipid interaction domains) [1] .
GAP-43 is mainly localized at the PM (plasma membrane) and contributes to the mechanism of axonal outgrowth in embryo and to axonal regeneration in the adult. This protein was also identified in peripheral and central glia cells [3] and developing muscle cells [4] , which points to a fundamental role for GAP-43 in cellular processes. GAP-43 is stably bound to membranes due to the S-acylation of Cys 3 and Cys 4 [5, 6] . Also, this protein is acetylated at its initial methionine [7] which, by analogy with the isoprenyl cysteine carboxyl methylation of CAAX-containing proteins (e.g. Ras, Rab and Rho families), could operate by increasing the hydrophobicity of the Nterminal region of GAP-43 or in participating in protein-protein interactions [8] . In addition, GAP-43 contains a basic effector domain organized in an α-helical secondary structure. This domain binds anionic lipids in both model and cellular systems [9, 10] , operates as a CaM (calmodulin)-binding region (aa [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] and contains a PKC (protein kinase C) phosphorylation site at Ser 41 [11, 12] . Phosphorylation of the effector domain disrupts its α-helical structure, prevents CaM/GAP-43 interaction and GAP-43-dependent clustering of PIP 2 [phosphatidylinositol (4, 5) -bisphosphate] at the PM [9, 10, 13, 14] .
GAP-43 is axonally transported in neurons by anterograde fast axonal transport [15] . This observation supports the idea that stable membrane association of GAP-43 is a consequence of posttranslational lipid modifications that occur early in the secretory Abbreviations used: aa, amino acids; AOTF, acoustical optical transmission filter; A phase, aqueous upper phase; Arf, ADP-ribosylation factor; ATB, antibiotics; 2-BP, 2-bromo hexadecanoic acid; BFA, brefeldin A; CaM, calmodulin; CFP, cyan fluorescence protein; CHO, Chinese hamster ovary; D phase, detergent-enriched lower phase; ECFP, enhanced cyan fluorescence protein; ER, endoplasmic reticulum; EYFP, enhanced yellow fluorescent protein; CHX, cycloheximide; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; FLIP, fluorescence loss in photobleaching; FRAP, fluorescence recovery after photobleaching; GalNAc-T, UDP-GalNAc:LacCer/GM3/GD3 N-acetylgalactosaminyltransferase; Gal-T2, UDP-Gal: GA2/GM2/GD2/GT2 galactosyltransferase; GAP-43, growth-associated protein-43; GAP-43 full , full-length wild-type GAP-43; N13 GAP-43, GAP-43 only containing the acylation motif (aa 1-13); GFP, green fluorescent protein; GPI, glycosylphosphatidylinositol; NA, numerical aperture; PAT, palmitoyl-acyl transferase; GFP-PH-PLCδ1, chimeric protein containing the PIP 2 -specific pleckstrin homology domain of phospholipase Cδ1 fused to GFP; HA, haemagglutinin; PIP 2 , phosphatidylinositol (4,5)-bisphosphate; PKC, protein kinase C; PM, plasma membrane; RE, recycling endosome; ROI, region of interest; Tf, transferrin; TGN, trans-Golgi network; TX-114; Triton X-114; YFP, yellow fluorescent protein. 1 These authors contributed equally to this article. 2 To whom correspondence should be addressed (email daniotti@dqb.fcq.unc.edu.ar).
pathway. In this regard, it was suggested that the ER (endoplasmic reticulum)-Golgi intermediate compartment is the initial site of GAP-43 acylation [16] . However, recent results [17, 18] suggest that acylation of this protein might occur at the Golgi level, in agreement with previous reports proposing this association and supporting the kinetic trap model for GAP-43 in such membranes [19] . In addition to the PM, the Golgi localization of GAP-43 has been widely documented [5, [20] [21] [22] . We have also previously described the presence of a truncated form of GAP-43, containing the acylation motif (aa 1-13, N13 GAP-43) fused to YFP (yellow fluorescent protein), in RE (recycling endosomes) [23] . Nevertheless, the mechanisms of intracellular transport (vesicular and/or adsorption/desorption) involved in the targeting of GAP-43 to the RE are not understood.
In the present study, we have investigated, in CHO (Chinese hamster ovary)-K1 cells, the membrane association, subcellular distribution and intracellular trafficking of the GAP-43 full (fulllength wild-type GAP-43) and the acylation motif of GAP-43 both fused to the N-terminal domain of spectral variants of GFP (green fluorescent protein). Using biochemical assays, confocal and video microscopy in living cells, we demonstrated that full and N13 GAP-43 are mainly acylated at the TGN (trans-Golgi network). At steady state, these proteins were localized at the TGN, PM and RE. The TGN pool observed at steady state represented a newly synthesized fraction of GAP-43 en route to the PM, whereas the RE-associated pool of these proteins represented a post-biosynthetic fraction originating from endocytosis through a pathway regulated by the small GTPase Arf (ADP-ribosylation factor) 6. Taken together, these results demonstrate that exocytic and endocytic vesicular carriers mediate intracellular trafficking of GAP-43 in a double acylationdependent process, and that the pool of GAP-43 associated to the endocytic recycling compartment is dynamic and exchangeable with the PM-associated pool.
EXPERIMENTAL Plasmids
The expression vectors pECFP-N1 [where ECFP, enhanced CFP (cyan fluorescence protein)], pEYFP-N1 (where EYFP, enhanced YFP), pECFP-C1 and pEYFP-C1 were from Clontech. Expression plasmids for N13 GAP-43-(CFP or YFP), (CFP or YFP)-K-Ras C14 , (CFP or YFP)-H-Ras C20 , N27 UDP-GalNAc-T (GalNAc:LacCer/GM3/GD3 N-acetylgalactosaminyltransferase)-CFP and N52 UDP-Gal-T2 (Gal:GA2/GM2/GD2/GT2 galactosyltransferase)-CFP were described previously [23, 24] . Mutations at Cys 3 and Cys 4 of N13 GAP-43-YFP and GAP-43 full were performed by directed mutagenesis using PCR. The plasmid encoding mouse GAP-43 full has also been described previously [25] and was used for subcloning into the pEYFP-N1 vector. The GPI (glycosylphosphatidylinositol)-YFP fusion construct was kindly supplied by Patrick Keller (Max-Planck Institute, Dresden, Germany). Iip33-CFP was obtained by subcloning the Iip33 cDNA into pECFP-N1. The plasmid encoding GFP-PH-PLCδ1 (chimeric protein containing the PIP 2 -specific pleckstrin homology domain of phospholipase Cδ1 fused to GFP), HA (haemagglutinin)-Arf6-Q67L and pEGFP-Rab11a (where EGFP, enhanced GFP) wild-type were received from Mark Lemmon (University of Pennsylvania School of Medicine, Philadelphia, U.S.A.), Julie Donaldson (National Heart, Lung, and Blood Institute, National Institutes for Health, Bethesda, MD, USA) and Maria Colombo (Universidad Nacional de Cuyo, Mendoza, Argentina) respectively.
Cell culture and DNA transfections
CHO-K1 cells (A.T.C.C.) were maintained at 37
• C, 5 % CO 2 , in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS (fetal bovine serum) and ATB (antibiotics, 100 μg/ml penicillin and 100 μg/ml streptomycin). Cells grown on coverslips were fixed for 15 min with paraformaldehyde and used for fluorescent microscopy, or grown onto Lab-Tek II chambered coverglass (Nalge Nunc International) for live cell imaging, or grown on Petri dishes for both live cell imaging and Western blot experiments. Cells were transfected with 0.6-1.2 μg/35 mm dish of the indicated plasmid using cationic liposomes (Lipofectamine TM ).
Subcellular distribution of fusion proteins at steady state
At 24 h after cell transfection, the cells were washed with cold PBS (140 mM NaCl, 8.4 mM Na 2 HPO 4 and 1.6 mM NaH 2 PO 4 , pH 7.5) and harvested by scraping for Western blot experiments as described by [26] or fixing for phenotypic analysis of subcellular distribution. Alternatively, cells were plated onto Lab-Tek II chambered coverglass, incubated for 36 h, and used in live cell imaging on a fluorescence confocal microscope (see below).
Synchronized expression and time course analysis of subcellular distribution of fusion proteins
For synchronized synthesis and time course analyses of subcellular distribution, CHO-K1 cells were grown in 60 mm dishes for Western blot experiments, onto coverslips for phenotypic analyses or onto Lab-Tek II chambered coverglass for live cell imaging and transfected as described above. At the moment of transfection, 50 μg/ml CHX (cycloheximide, SigmaAldrich) was added. Then, 5 h after transfection, FBS (10 % v/v final concentration) was added to the medium and 3 h later CHX was removed by three washes with DMEM containing FBS and ATB. Where indicated, medium was supplemented with 2-BP (2-bromo hexadecanoic acid, Fluka), BFA (brefeldin A; 1μg/ml, Sigma-Aldrich) or vehicle (DMSO or methanol). Time course expression, membrane association and subcellular distribution were analysed by Western blot and fluorescence microscopy on both fixed and live cells.
Subcellular fractionation and TX-114 (Triton X-114) partition assay
Cells grown onto 60 mm dishes were washed with cold PBS and harvested by scraping in PBS-PIM (PBS containing protease inhibitors). Extracts were centrifuged at 4
• C for 5 min at 13 000 g and resuspended in 400 μl of 5 mM T-PIM [buffer T (Tris/HCl, pH 7.0) in the presence of protease inhibitors (Sigma-Aldrich)]. Pellets were dispersed by repetitive pipetting and vortexing. After 30 min of incubation in T-PIM, pellets were passed 60 times through a 25-gauge needle. Nuclear fractions and unbroken cells were removed by centrifuging twice at 4
• C for 5 min at 600 g. Supernatants were then ultracentrifuged at 4
• C for 1 h at 400 000 g using a TLA 100.3 rotor (Beckman Coulter). The supernatant (S1 fraction) was removed, and the pellet (P1 fraction) was resuspended in 400 μl of T-PIM. Both fractions were further ultracentrifuged at 400 000 g and the supernatant of S1 fraction was removed (S fraction) and the pellet of P1 fraction was resuspended in 400 μl of T-PIM (P fraction). 100 μl of 5% (v/v) TX-114 in T-PIM was added to the S and P fractions and incubated at 4
• C for 1 h. Then, samples were incubated at 37
• C for 3 min and centrifuged at 13 000 g. The aqueous upper phase, A, and the detergent-enriched lower phase, D, were separated and extracted again with detergent and aqueous solutions respectively. The resulting samples were adjusted to equal volumes and the detergent content and proteins were precipitated with chloroform/methanol (1:4, v/v) for Western blot analyses.
2-BP treatment
The stock solution of 2-BP (0.42 M) was prepared in DMSO. CHO-K1 cells expressing recombinant proteins were incubated with 2-BP (in the range 25-150 μM) or vehicle for control cells. To analyse the effect of 2-BP on newly synthesized proteins, 2-BP was added to the culture medium 30 min before CHX withdrawal to allow for an adequate 2-BP internalization to inhibit PAT (palmitoyl-acyl transferase) activity [27] . After CHX withdrawal, cells where washed 3 times with DMEM and further incubated with 2-BP for 3 h before harvesting for Western blot experiments or confocal microscopy. All experiments, except for those of Figure 5 , were performed using 2-BP at 150 μM. To analyse the effect of 2-BP on the steady state subcellular distribution of fluorescent proteins, CHX and 2-BP were added to culture medium 24 h after cell transfection (Western blot experiments) or 36 h after plating transfected cells into Lab-Tek II chambered coverglass.
Confocal microscopy and image acquisition
Confocal images were collected using a Carl Zeiss LSM5 Pascal laser scanning confocal microscope (Carl Zeiss AG) or an Olympus FluoView FV1000 confocal microscope (Olympus Latin America), the latter equipped with an AOTF (acoustical optical transmission filter) and a high speed diffraction grating in combination with a variable slit to select the different emission wavelengths to be detected. A multi-line Argon laser (458, 488 and 514 nm) and two Helium Neon lasers (543 nm and 633 nm respectively) were used in both microscopes. For the FluoView FV1000 microscope, CFP was detected by using laser excitation at 458 nm, with a 458/514 nm excitation dichroic mirror and the fluorophore emission collected between 475 and 495 nm. YFP was acquired by using laser excitation at 514 nm, with a 458/514 nm excitation dichroic mirror and emission collected between 530 and 560 nm. Alexa Fluor ® 647 was acquired with a laser excitation at 633 nm, a 488/543/633 nm excitation dichroic mirror, and a 650 nm long-pass emission filter. For CFP-YFP or CFP-YFP-Alexa Fluor ® 647 colocalization experiments, images were sequentially acquired in line mode. This minimizes bleedthrough between channels.
For the Zeiss LSM5 Pascal microscope, fluorescence from YFP was detected by using a 514 nm excitation laser line, a 458/514 dichroic mirror and a 530-560 nm bandpass emission filter, and fluorescence from CFP was detected by using a 458 nm excitation laser line, a 458/514 dichroic mirror and a 475-490 nm bandpass emission filter.
Live cell experiments were performed at 35 + − 2 • C (Tritech DigiTherm temperature controller and a heating adapter plate, CA, U.S.A.) on the Olympus FluoView FV1000 confocal microscope. For colocalization experiments, a 100× UPlanSApo oil immersion/1.4 NA (numerical aperture) (Olympus, Japan) objective was used with a 3× digital zoom, and using an appropriated pinhole to obtain 1 Airy unit for the shortest wavelength (optical slice 0. After acquisition, images of cotransfected specimens were spectral unmixed using the spectral response of each fluorochrome. The spectral linear unmixing of fluorochromes from co-transfected cells was performed on the spectral deconvolution application of the Fluoview Software, without background subtraction. The performance of the spectral deconvolution algorithm was evaluated by deconvolution of lambda scans from single transfected cells, in the conditions described above for co-transfected specimens, giving no significant signal in the GFP channel when images of single transfected GAP-43-YFP cells were linearly unmixed. The same was observed when GFP fluorescence was evaluated. Phenotypic analyses were performed on the Carl Zeiss LSM5 Pascal laser scanning confocal microscope using a 63× PlanApochromat oil immersion/1.4 NA (Carl Zeiss AG, Germany) with a fully opened pinhole.
Phenotypic analyses of subcellular distribution
The phenotypic analyses were performed essentially as we have previously described [26] , except that for GAP-43 the phenotypes at steady state were classified as TGN + PM, PM and PM + RE, according to morphological and fluorescence intensity differences and triple labelling experiments using specific markers for organelles (see Figures 3 and 4 and Supplementary Figure  S3 ). The TGN + PM phenotype is described as perinuclear dispersed tubular structures and PM staining as average intensity fluorescence greater than cytoplasm; the PM phenotype is PM staining with no significant fluorescence from intracellular compartments; and the PM + RE phenotype is PM staining and where perinuclear structures contain both tubular dispersed structures and a circular structure characteristic of RE, which is distinguishable because of greater average fluorescence intensity than those of dispersed tubules. The average fluorescence intensity on these structures was estimated with the threshold function of the Metamorph software (Methamorph ® 4.5, Molecular Devices). For exocytic transport experiments, the phenotypes were classified as TGN > PM, TGN = PM, PM > TGN and PM + RE, according to their spatial organization and average fluorescence intensities, estimated as described above, and using specific markers for organelles. Statistical significance (P) was determined using the t test on the average frequency of phenotypes. 
RESULTS
The full-length and N-terminal domain of GAP-43 localize, at steady state, on the PM and perinuclear structures
To investigate the intracellular transport and subcellular distribution of GAP-43 in CHO-K1 cells, we constructed fusion proteins consisting of GAP-43 full or the acylation motif (MLCCMRRTKQVEK) of GAP-43, N13 GAP-43, fused to the Nterminal domain of CFP or YFP ( Figure 1A ). The membrane association and the extent of post-translational modification of these constructs were analysed by ultracentrifugation and TX-114 partition assays ( Figure 1B ) [26] . More than 70 % of N13 GAP-43 and 60 % of GAP-43 full were found to be associated with the P fraction after ultracentrifugation. On the other hand, more than 90 % of YFP was recovered in the S fraction, whereas the YFP fused to a GPI attachment signal, GPI-YFP, was mostly recovered in the P fraction. 83 % and 24 % of P-fraction-associated N13 GAP-43 and GAP-43 full respectively, were found enriched in the TX-114 D phase, reflecting a higher hydrophobic character for N13 GAP-43 ( Figure 1B) . Similarly, when the S fraction was analysed, 39 % and <10 % of N13 GAP-43 and GAP-43 full respectively, were found to be enriched in the D phase. YFP was found to partition into the A (aqueous) phase and GPI-YFP into the D phase [23, 26] . We next analysed the subcellular distribution of co-expressed N13 GAP-43-CFP and GAP-43 full -YFP, using live-cell confocal microscopy. N13 GAP-43-CFP and GAP-43 full -YFP were colocalized at the PM and perinuclear structures (Figure 2A ), suggesting that molecular signals for localization on these compartments are present at the N-terminal polypeptide of GAP-43 (acylation, basic residues 6, 7 and 9, and/or acetylation) [7] .
At steady state, GAP-43 full and N13 GAP-43 are distributed between PM, TGN and RE
It was previously demonstrated that GAP-43 transits the exocytic pathway to arrive at the PM [15, 16, 28] . In addition, we described the presence of N13 GAP-43 both at TGN structures and RE [23] .
To extend our previous observation and to characterize further in detail the perinuclear organelles to which GAP-43 (full-length and truncate) binds at steady state, we performed an extensive in vivo colocalization analysis with markers of perinuclear organelles. No colocalization was observed between GAP-43 (GAP-43 full and N13 GAP-43) and the major histocompatibility complex class II invariant chain isoform-CFP (Iip-33), or for N52 galactosyltransferase 2-CFP (Gal-T2), an ER and a proximal Golgi-resident protein respectively ( Figure 2B ). However, a fraction of perinuclear localized GAP-43 full and N13 GAP-43 was found colocalizing with GalNAc-T, a TGN-resident protein [23, 29, 30] (Figure 2B ). Moreover, some of the perinuclear structures decorated with GAP-43 full and N13 GAP-43 were found colocalizing with endocytosed human Alexa Fluor ® 647-Tf (transferrin) (Figure 2B ), or Rab11 (results not shown), two established RE markers [23] . Interestingly, we also demonstrated that the fractional concentration of GAP-43 full and N13 GAP-43 on membranes from RE is independent of their expression level (Supplementary Figure S1 at http://www.BiochemJ.org/bj/421/ bj4210357add.htm). It should be also remarked that a similar subcellular distribution for ectopically expressed GAP-43 full and N13 GAP-43 was observed in the undifferentiated neuroblastoma cell line SH-SY5Y, suggesting that sorting mechanisms involved in organelle localization of GAP-43 are also operative in this cell line (Supplementary Figure S2A at http://www.BiochemJ.org/bj/421/bj4210357add.htm). Moreover, confocal microscopy analysis revealed that immunoreactivity for endogenous GAP-43 partially colocalized with endocytosed Tf in a perinuclear region from retinoic acid-treated Neuro2A neuroblastoma cells, demonstrating that a fraction of endogenously expressed GAP-43 in Neuro2A was present at the RE (Supplementary Figure S2B) .
To further evaluate the steady state subcellular distribution of GAP-43, we explored in vivo the effect of BFA on the perinuclear localization of GAP-43 by confocal microscopy. BFA reversibly inhibits the guanine nucleotide exchange factors specific to the GTPase Arf1, which causes redistribution/fusion of cis-/medialGolgi with the ER, and redistribution/fusion of TGN with the RE [31] . In control cells, N13 GAP-43 and GAP-43 full decorated perinuclear structures, with some of them colocalizing with Tf but not with Gal-T2 ( Figure 2C ). After BFA treatment, there was a significant redistribution of Gal-T2, but not GAP-43, to the ER. On the other hand, there was a significant increase in the proportion of colocalization between GAP-43 and Tf in perinuclear structures. These results demonstrate that the perinuclear structures containing GAP-43 at steady state mainly correspond to the TGN and RE.
Newly synthesized GAP-43 is mainly associated with TGN, but not with RE; role of dual acylation
The presence of acylated GAP-43 at a given compartment could result from the balance of GAP-43 membrane adsorption/desorption and/or entry and exiting of vesicular carriers containing this protein. In addition, PAT activity on a given membrane also contributes to GAP-43 concentration, by adsorption of nonacylated protein. To discriminate between these possibilities, we first investigated the organelle/s where newly synthesized GAP-43 is primarily associated by quantifying the phenotypic subcellular distribution of N13 GAP-43 and GAP-43 full after synchronized protein expression ( Figure 3 ). After CHX withdrawal (t = 0 h), the subcellular distribution of N13 GAP-43 and GAP-43 full at different times was evaluated by subcellular phenotype classification according to morphological, fluorescence intensity differences and triple labelling experiments using specific markers for organelles. being clearly evident at 7 h after CHX withdrawal. However, at this time, the PM > TGN phenotype was more frequent for N13 GAP-43 (60 %) than for GAP-43 full (15 %), suggesting that GAP -43 full had been transported less efficiently from TGN to PM. On the other hand, the association of GAP-43 with membranes from the RE was clearly observed at 24 h after CHX withdrawal, with N13 GAP-43 being observed early in this organelle at 7 h, demonstrating that the RE-associated GAP-43 is a postbiosynthetic pool probably resulting from endocytosis. Additionally, we also analysed subcellular distribution of GAP-43 when vesicular traffic was reduced by incubation at 16
• C ( Figure 4A ). Soon after synthesis at 37
• C, N13 GAP-43 and GAP-43 full proteins localized more frequently at the TGN [Figures 4B and 4C, 37
• C (7 h)], which was clearly different to the phenotypic subcellular distribution observed at steady state conditions ( Figure 4C , steady state). Moreover, incubation at 16
• C caused an additional increase in the number of cells expressing N13 GAP-43 and GAP-43 full at the TGN [ Figure 4C , 16
• C (7 h)], which was later reversed by further incubation of the system at 37
• C [ Figure 4C , 16 To study PAT activity in the TGN-association of newly synthesized N13 GAP-43 and GAP-43 full , we analysed the effect of PAT inhibition on this process by using 2-BP ( Figure 5A ). Treatment with 100 or 150 μM 2-BP almost completely inhibited membrane association, particularly to TGN, of both N13 GAP-43 and GAP-43 full ( Figure 5B ). Notably, 50 μM 2-BP inhibited membrane association of full , although at this 2-BP concentration there was a significant amount of N13 GAP-43 associated to TGN. Taken together, these results show that PAT activity is required for TGN association of GAP-43, and demonstrate that sequences outside the acylation motif of GAP-43 full probably affect the enzymatic process of lipid modification of this protein when compared with N13 GAP-43, in spite of the fact that both proteins contain the same acylation motif. Supporting the role of acylation for proper GAP-43 membrane association, it was also observed that a double mutant at Cys 3 and Cys 4 of N13 GAP-43 and GAP-43 full occurred diffusely throughout the cells, characteristic of a cytosolic protein ( Figure 5C ). We next analysed in vivo the subcellular distribution of single acylation mutants of N13 GAP-43 and GAP-43 full at steady state ( Figure 5C ). The point mutation at Cys 3 in N13 GAP-43 caused an accumulation at the cytosol and TGN and also disrupted RE association, but did not affect their PM association. On the other hand, the point mutation at Cys 3 in GAP-43 full and mutation at Cys 4 in N13 GAP-43 and GAP-43 full disrupted the association with the PM, drastically reduced their TGN association, and resulted in an accumulation at the cytosol. The differences observed between GAP-43 mutants with regard to their capacity to bind membranes could be due to differences in their ability to be post-translationally lipid modified, as previously reported [5] . These results suggest that efficiency in fatty acylation of GAP-43 at the TGN could modulate its incorporation into vesicular transport carriers directed to the PM, and also indicate that a dual acylation is necessary for its proper RE localization.
A de/reacylation cycle does not account for the accumulation of GAP-43 at the TGN As indicated above, a fraction of GAP-43 localized at the TGN at steady state. From these and other published results [5, 22, 27] , we thought that the presence of this TGN-associated pool of GAP-43 could be due, at least in part, to two mechanisms: the first involving a fast deacylation step at the PM, thereby disrupting the membrane association of the protein, and a later acylation by TGN-specific PAT, causing a kinetic trapping of the protein in the organelle [27, 32] . The second mechanism implies a slow, rate-limiting transport in the secretory pathway after GAP-43 had been synthesized and acylated at the TGN. To analyse these possibilities, we first tested in vivo the kinetics of deacylation of GAP-43 full and N13 GAP-43 at steady state by treating the cells with 2-BP and CHX at different times, followed by TX-114 partition assay. As control, we analysed, at the same conditions, the TX-114 partition of newly synthesized GAP-43 full and N13 GAP-43 in cells treated with 2-BP. PAT inhibition prevented the partition of newly synthesized GAP-43 full and N13 GAP-43, but not GPI-YFP (results not shown), to the detergent phase, which indicates that the non-acylated protein was unable to partition into this fraction ( Figure 6A ). The analysis of the effect of 2-BP on the steady-state pool of GAP-43 full and N13 GAP-43 revealed that there was no significant deacylation of the expressed protein for a wide range of time periods (0, 3 and 6 h) ( Figure 6B , as shown by the fraction of GAP-43 present in the aqueous phase from S fraction). These results were further confirmed by using live cell confocal microscopy ( Figure 6C ). Taken together, results from these experiments (Figures 3-6 ) demonstrate the same subcellular trafficking itinerary for N13 GAP-43 and GAP-43 full (TGN→PM→RE). Moreover, TGN accumulation of GAP-43 at steady state is probably due to a slow, rate-limiting transport to PM after it is synthesized in the cytosol, rather than to a process involving deacylation and later acylation at the TGN. photobleaching) experiments were performed in CHO-K1 cells previously treated with CHX to reduce the pool of TGNassociated GAP-43 ( Figure 7B ). To that end, the RE was photobleached by confocal laser microscopy and the region was then monitored for fluorescence recovery. A typical FRAP experiment is shown in Figure 7 (C, panel i, upper row). In this cell, prior to photobleaching, N13 GAP-43-YFP appears as a bright spot associated with the RE, colocalizing with Tf. Following focal irradiation, this fluorescence was considerably reduced. Subsequently, the fluorescence began to rapidly reappear in the RE recruitment of N13 GAP-43-YFP. A quantification of this recovery process is shown in Figure 7(C, panel ii) . Clearly, results from these experiments demonstrate the dynamic nature of GAP-43 (GAP-43 full and N13 GAP-43) trafficking to the RE from PM in CHO-K1 cells.
To demonstrate the role of vesicular transport in PM to RE trafficking of GAP-43, FRAP experiments in tannic acid-treated cells were performed. The impermeable fixative tannic acid avoids both vesicular fusion and endocytosis at the PM [33, 34] . To check first whether tannic acid impairs internalization by vesicular transport in CHO-K1 cells, we followed Tf endocytosis. In control cells, Tf was localized in the perinuclear endosomal compartment, whereas in cells treated with tannic acid, it was only present at the cell surface ( Figure 7A) . As additional control, we verified that tannic acid did not significantly affect the non-vesicular redistribution of K-Ras from PM to RE after valinomycin treatment [26] (Figure 7C, panel ii) . However, we observed that in tannic acid-treated cells, trafficking of GAP-43 to RE was drastically reduced ( Figure 7C, panel ii) . As control, we also investigated the effect of tannic acid on the internalization of GPI-YFP via the clathrin-independent endocytic pathway [35] . Similar to GAP-43, RE/Golgi complex refilling of GPI-GFP was considerably inhibited in tannic acid-treated cells ( Figure 7C , panel ii). Taken together, the results from these experiments clearly indicate vesicular trafficking of GAP-43 from PM to RE.
Expression of Arf6(Q67L) causes accumulation of GAP-43 into enlarged vacuolar membranes
Internalization of many GPI-anchored proteins and the double acylated H-Ras occurs by a clathrin-independent pathway regulated by the small GTP-binding protein Arf6 (Figure 8 ) [36, 37] . It has been described that expression of the constitutively active GTPase-deficient Arf6 mutant, Arf6(Q67L), perturbs trafficking of those cargo proteins transported through the Arf6-associated pathway, resulting in cargo accumulation in vacuolar structures that are enriched in PIP 2 and actin. We examined the effect of expression of Arf6(Q67L) on GAP-43 trafficking and we found that GAP-43 was at the PM and associated with vacuolar structures decorated with the fluorescent probe GFP-PH-PLCδ1 (Figure 8 ). These results show that GAP-43 is internalized through the Arf6-associated pathway and supports the notion of vesicular transport in the trafficking of this acylated peripheral protein from PM to endosomal compartments.
DISCUSSION

GAP-43 is acylated mainly at the TGN
The presence of GAP-43 at the TGN, early after its synthesis, allows us to identify this subcellular compartment as the place where the lipid modification of GAP-43 occurs. The pharmacological inhibition of acylation with 2-BP completely disrupts TGN (and also other membrane) association, further confirming that this adsorption is a PAT activity-dependent process. In addition, double mutation of Cys 3 and Cys 4 of GAP-43 completely disrupts membrane association. Cell incubation at 16
• C, which inhibits vesicular transport, induced an increase in the number of cells expressing GAP-43 at the TGN, thus confirming that the initial adsorption of newly synthesized GAP-43 mainly occurs on this organelle. However, under this condition, a minor fraction of GAP-43 was also found localized at the PM, suggesting the presence of PATs in this membrane, which were able to acylate GAP-43, although less efficiently, than the TGNassociated PAT. In this regard, it was proposed that acylation could occur in different compartments besides the TGN [38] . In contrast with previous results [16] , we were not able to observe in CHO-K1 cells any association of newly synthesized GAP-43 with the ER-Golgi intermediate compartment.
The requirement of acylation of GAP-43 for TGN adsorption suggests that the enzyme/s catalysing this post-translational modification (PAT) is/are present at the TGN. PATs are multiple spanning membrane proteins containing a conserved DHHC (aspartate-histidine-histidine-cysteine) domain. In all, five PATs have been so far described to catalyse the acylation of GAP-43 (DHHC2, 3, 7, 15 and 17) [18, 39] , with the subcellular distribution and tissue expression of these proteins having already been previously characterized [18, 40] . DHHC2 was found to be observed in membranes from the ER and Golgi complex, whereas DHHC3, 7, 15 and 17 were discovered mainly associated with the Golgi complex. DHHC7 and 17 are ubiquitously expressed in tissues, with GAP-43 being highly expressed in the brain [40] . Therefore, DHHC7 and 17 are excellent candidates for GAP-43 acylation at the TGN, for both neuronal and non-neuronal cells. The ubiquitous tissue expression of DHHC5 and 21 and their PM localization [40] suggest that these PATs could be also involved in the PM acylation of GAP-43, although it remains to be demonstrated.
Vesicular carriers mediate TGN → PM → RE trafficking of GAP-43
TGN to PM transport of GAP-43
Cell incubation at 16
• C, which reduces vesicular transport, induced an increase in the TGN association of GAP-43. Using FLIP experiments, we observed that incubation of cells at 20
• C significantly reduced the decay time of the TGN-associated pool of GAP-43 and prevented its targeting to PM. Moreover, fixation of PM with tannic acid, which prevents the fusion of exocytic vesicles, but not the adsorption of proteins (i.e. K-Ras), caused an increase of discrete structures dispersed throughout the cytoplasm decorated with GAP-43 full and N13 GAP-43 without affecting Golgi complex structure (Supplementary Figure S6 at http://www.BiochemJ.org/bj/421/bj4210357add.htm). These results support the idea that molecular signals present in the first 13 aa are sufficient for inclusion into the same vesicular carriers. Although positively charged aa at position 6, 7 (arginine-arginine) and 9 (lysine) of GAP-43 contribute to membrane binding and polarized sorting, they are not absolutely necessary for inclusion into TGN to PM vesicular carriers [7, 28] . Therefore, in agreement, our results show that dual acylation, into a cluster of hydrophobic aa and/or acetylation, operates as a dominant signal for GAP-43 inclusion into vesicular carriers, whose selectivity could be modulated by the presence of Arg 6 , Arg 7 and Lys 9 residues. We next attempted to identify the kind of carrier involved in TGN to PM transport of GAP-43. It was found that BFA had no appreciable effect on the transport of newly synthesized N13 GAP-43 from TGN to PM, suggesting that in these processes, the BFA-sensitive guanine nucleotide exchange factors might not be participating (Supplementary Figure S7 at http://www.BiochemJ.org/bj/421/bj4210357add.htm), and therefore discarding an essential role of clathrin-coated vesicles in the TGN exiting of GAP-43. These results are in agreement with those recently published describing that selective knockdown of clathrin does not affect the sorting of proteins to the apical domain of MDCK cells [41] , comparable with the axonal delivery of proteins in neurons. Thus our results suggest a clathrin-independent and double acylation-dependent process operating in the TGN exiting of GAP-43 in different cell types. It was also observed that there are kinetic differences with respect to times of exiting from and arrival at each subcellular compartment, with N13 GAP-43 being transported quicker to the PM than GAP-43 full , suggesting that sequences outside the acylation motif of GAP-43 modulate its vesicular transport. In addition, we also found that single acylated mutants of N13 GAP-43 were inefficient in reaching the PM and concentrated at the TGN. In particular, this phenomenon was clearly evidenced for N13 GAP-43 C3S . Moreover, treatment with 50 μM 2-BP did not disrupt the TGN association of N13 GAP-43, but severely inhibited its PM targeting, suggesting that the TGN-associated N13 GAP-43 pool is single acylated and hence unable to be efficiently transported to PM, supporting a role of dual acylation for the proper inclusion of GAP-43 into TGN to PM vesicular carriers.
PM to RE transport of GAP-43
The role of vesicular transport in PM to RE trafficking of GAP-43 was demonstrated by FRAP experiments in tannic acid-treated cells (Figure 7 ). This was further confirmed by the overexpression of Arf6(Q67L), which affects endocytic trafficking by inhibiting the fusion of early endocytic vesicles with sorting endosomes [36] (Figure 8) . A similar result was also observed for double acylated H-Ras. Arf6 promotes the internalization of PM proteins via clathrin-dependent [42] [43] [44] and clathrin-independent [36, 37] endocytosis through activation of phosphatidylinositol-4-phosphate 5-kinase to generate PIP 2 . We found that the expression of a dominant-negative mutant of the epidermal growth factor receptor pathway substrate clone 15, which selectively affects clathrin-mediated endocytosis, did not significantly affect GAP-43 trafficking to the RE, suggesting that clathrin-coated vesicles are not participating in the endocytic process of GAP-43 (results not shown). We also observed that single acylated mutants of GAP-43 did not arrive at the RE compartment, supporting a role of dual acylation for endocytic trafficking of GAP-43 ( Figure 5C ). Thus, these results indicate that the exocytic trafficking of GAP-43, from the TGN to PM as well as its endocytic delivery to RE, is mediated by vesicular carriers. Moreover, this supports the notion that dual acylation is required for RE delivery of acylated proteins [23] .
Deacylation is not involved in the retrograde transport of GAP-43 to TGN
We demonstrated that, at steady state, a fraction of N13 GAP-43 and GAP -43 full is present at the TGN probably as a consequence of a rate-limiting TGN exit of newly synthesized protein and not through a de/reacylation mechanism [27, 32] , in which CHO-K1 cells could operate over a time scale of hours. Moreover, we demonstrated that the pool of TGN-associated GAP-43 full was reduced after 6 h of CHX treatment (results not shown). These results discard the possibility that a retrograde transport of GAP-43 from PM (or other endomembranes) to TGN, involving vesicular carriers or a desorption facilitated process (protein mediated, without deacylation), is the principal contribution to the steady state TGN localization of GAP-43.
Concluding remarks
To sum up, in this work we have shown that the intracellular transport and main destinations (TGN, PM and RE) of GAP-43 depend on its dual acylation state. This molecular requirement is important for inclusion into exocytic and endocytic vesicular carriers. We showed that there are kinetic differences with respect to times of exiting from and arrival at each subcellular compartment, with N13 GAP-43 being transported faster to PM than GAP-43 full , suggesting that sequences outside the acylation motif of GAP-43 modulate its acylation state and vesicular transport. The intracellular trafficking of GAP-43 was demonstrated to be complex, resulting from a dynamic interplay between its exocytic and endocytic transport and PAT-dependent membrane adsorption. In particular, we have described for the first time the presence of GAP-43 at the RE, along with the molecular requirements necessary for this subcellular location. What is the potential role of GAP-43 at the RE? As already mentioned, the basic effector domain of GAP-43 participates in clustering of PIP 2 , which can be blocked by Ser 41 phosphorylation [14] . Moreover, it is known that the phosphorylated form of GAP-43 at Ser 41 by classical and novel isoforms of PKC [45] stabilizes long actin filaments and plays an important role in actin skeleton reorganization underlying growth cone motility and adhesion to substrate [46] [47] [48] . In addition, it has been shown that classical PKCα and PKCβII can associate to membranes of the RE after phorbol ester stimulation in HEK-293 (human embryonic kidney 293) cells [49] and CHO-K1 cells (A. Trenchi, G. A. Gomez and J. L. Daniothi, unpublished work). Taken into consideration all these findings and those described in the present study, we hypothesize that GAP-43, probably modulated by PKC phosphorylation, could be regulating vesicle formation and transport at the RE through its interaction with polyphosphoinositides and actin, as was previously described at the cytoplasmic leaflet of the PM [14, 50] .
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FRAP and FLIP experiments were performed in an Olympus FluoView FV1000 confocal microscope using a 20× UPlanApo oil immersion/0.8 NA (Olympus, Japan) objective. In these experiments, the pinhole was fully opened in order to minimize changes in fluorescence detection due to Z-drift occurring during time lapse imaging.
Before performing FRAP and FLIP experiments, we standardized bleaching protocols to avoid significant reversible photobleaching as previously observed for YFP using standard protocols [1] . For standardization, we employed YFP-expressing cells, which were fixed with 4 % paraformaldehyde in PBS for 20 min at room temperature (25
• C) and incubated at the same conditions as that used for FRAP and FLIP experiments on live cells (DMEM without phenol red, 35
• C, Lab-Tek II coverglass, bleach ROI size, imaging pre-and post-bleach acquisition settings). For FRAP experiments, no significant photoreversibility of YFP (< 10 %, compared with 40-50 % using standard protocols) was observed after photobleaching using: 50× digital zoom, 60 scans of a 200 pixels × 200 pixels bleaching ROI (1024 pixels × 1024 pixels resolution), 8 μs/pixel, direct scan, 100 % transmission of both 458 and 488 nm laser lines (30 mW) and 20× UPlanApo oil immersion/0.8 NA objective. Under these conditions, YFP fluorescence after bleaching was lower than 20 % of its initial value and bleaching time was 1 min, with not significant photodecomposition of Alexa 647 (Alexa Fluor ® 647). Pre-and post-bleaching images (20 and 1000 images respectively) were acquired each 2 s, from a 320 pixels × 320 pixels ROI (512 pixels × 512 pixels resolution) using the same objective and a zoom factor of 8. Images were acquired sequentially in each channel (YFP and Alexa 647). To minimize bleaching during acquisition, a BS 20/80 beam splitter was used instead of dichroic excitation mirrors. For FLIP experiments, bleaching of the ROI and full image acquisition was performed every 2 min. Full images were acquired using the same acquisition parameters described above for pre-and post-bleaching images in FRAP experiments.
Quantitative image analysis for FRAP and FLIP experiments
For FRAP experiments, the average fluorescence intensity at each time point of pre-and post-bleaching images was measured in a region (75 pixels × 75 pixels) empty of cells to determine the background level, a region corresponding to the bleached area (Alexa 647-Tf positive pericentriolar compartment) and a region corresponding to the entire cell. From these data, we obtained the bleached area (A BA ), the background area (A BG ) and the rest of the cell (A outside ) area (A outside = A cell − A B ) and the fluorescence density (δF) of the bleached area (BA) (δF BA ) and the rest of the cell (δF outside ) at each time i, as follows:
where GV represents the grey value of a given pixel, and j (GV ) is the sum of grey values of the j pixels that represent the selected area (BA, BG or outside). Grey values and area sizes were measured with Metamorph software. From the above data we defined the parameter Q(i) at each time i:
The extent of bleaching (α) is calculated as:
where time = 0 corresponds to the first frame after bleaching, and time = −t is the last frame before bleaching. From these parameters, we plotted the ED (Exchange Dynamics) of the recovery process according to the equation:
where the middle point indicates multiplication between factors. We rationalize that, instead of plotting the typical FRAP equation, i.e. the recovered fraction [2] , the recovery process depends on the extent of bleaching (α), due to the space where molecules are moving is finite and the steady state distribution of molecules between different compartments, i.e. the experiment initial condition. Wu et. al. [3] observed the effect of this finite space on FRAP experiments of soluble GFP and suggested an equation that resumes to ED equation for Q(− t) = 1, which is valid for a fluorescent molecule that is homogenously distributed between the BA and the rest of the cell before photodecomposition.
Consequently, by determining Q from pre-bleaching values, we normalized the FRAP data similar to the classical representation and corrected both for finite space effect (an effect observed when significant reduction of cell fluorescence is induced in the bleaching process) and for small fluctuations due to cell movement and/or Z-drift. In addition, using a fluorescent organelle marker, we precisely determined the BA, both early after bleaching, when fluorescence is not significant, and at longer times, where organelle motion is more likely to occur. For FLIP experiments, the average fluorescence intensity at each time point was measured both on the TGN region of the bleached cell and on the entire reference cell (non-bleached cell) as follows:
The background was measured as described above for FRAP experiments. The TGN fluorescence intensity (as % of initial) was measured as:
where R(0) is the ratio from the first image, before bleaching.
Tannic acid treatment
Tannic acid treatment was performed as described in [4] with minor modifications. Briefly, cells were washed with cold PBS and incubated at room temperature with 1 % tannic acid (MP Biomedicals, U.S.A.) in PBS (pH 7) for 10 min. Then, tannic acid was removed and cells were incubated in conditions for Tf endocytosis and/or FRAP experiments as described below. Tannic acid effect was tested by analysing its effect on Tf internalization. Tannic acid treated cells were incubated for 30 min with Alexa 647-Tf, and then washed with DMEM/0.2 % BSA to remove unspecifically bound Tf. Finally, cells were washed with PBS and fixed with paraformaldehyde. Cells were then analysed by confocal microscopy. Tannic acid treatment did not prevent Tf binding to PM (results not shown).
For FRAP experiments, cells grown onto Lab-Tek II chambered coverglass (60 h after transfection) were incubated for 1 h with Alexa 647-Tf and then treated or not with tannic acid. Cells were washed with DMEM in the absence of antibiotics, FBS or phenol red, and used in FRAP experiments for a period of time no longer than 45 min.
To investigate the effect of tannic acid on the intracellular transport of newly synthesized GAP-43, transfected cells were treated with tannic acid during 10 min after 2.5 h CHX withdrawal. After tannic acid treatment, cells were incubated in fresh growth medium (without phenol red) containing FBS and ATB for 30 min and imaged live by confocal microscopy.
Endocytosis of Alexa 647-conjugated Tf
To label the endocytic recycling compartment of CHO-K1 cells, 14 μg/ml of human Alexa 647-Tf (Molecular Probes) was added to the culture medium for 1 h. After Tf incubation, cells were washed and fixed or analysed by confocal microscopy. In experiments of synchronized synthesis of fusion proteins, Tf was added to the culture medium at the moment of CHX withdrawal, except for synchronized expression in the presence of BFA, in which Tf was added 60 min before CHX withdrawal. Tf was maintained in the extracellular milieu during the time course experiments to avoid clearance of the internalized ligand.
Pre-processing of images and fractional concentration measurements
Images (three-dimensional, XYZ stacks) were acquired from three channels, a CFP channel corresponding to N27 GalNAc-T-CFP, a TGN marker; a YFP channel corresponding to N13 GAP-43-YFP or GAP-43
full -YFP and a Cy5 (indodicarbocyanine) channel corresponding to Alexa 647-Tf fluorescence, an RE marker.
Significant fluorescent pixels were isolated from raw (R) images of the YFP channel by applying the following sequence of operations. First, we applied the next equation to the raw image: Ch,i have 0 and 1 values. Additionally, because single pixels in these masks are probably due to photonic noise, and physically there are not objects lower than 5 pixels in diameter (optical resolution in our acquisition conditions), we exclude from [M] Ch,i single significant pixels and pixels belonging to objects whose area is lower than 5 pixels (including holes).
Once obtained, [M] Ch,i , significant pixels (i.e. whose intensity different from background noise) in the raw image were selected by multiplying each ij element of [Im] Ch,i R with the corresponding ij element of [M] Ch,i , i.e:
Ch,i ij
The set of [Im] Ch,i SP ij elements constitute an image (stack) with significant information, which is necessary for the following analyses. Note that by selecting the pixels in this way, we did not fix a background value; which is dependent, for example, on auto-fluorescence contribution, Z-plane, etc. Assuming this option, we note that the fluorescence is related to the number of fluorescent molecules, but is not necessarily a directly proportional relationship. This is different from simply subtracting background, where there is not a golden rule to determine it, which only causes an ordinate displacement along the y axis in a plot of intensity as a function of concentration of fluorescent molecules.
Then Alexa 647 ) were obtained as described for YFP, except that the measurement of background level in the organelle channel was determined in each plane around the organelle (TGN or RE). Since a fraction of N27 GalNAc-T-CFP was present in the ER, the background level for this channel was determined in the cytoplasm of cells (note that the GalNAc-T marker is more concentrated on TGN than ER). For Alexa 647-Tf, the background was determined in the cytoplasm of cells. In CHO-K1 cells, the RE compartment is the biggest object in the Tf channel, so to create a mask corresponding to this compartment we applied a second object size threshold to [M] Alexa 647 to only select this compartment for latter analyses.
After creating each mask from organelle channels, we determined the volume of each organelle using the following equation: FVD at the plasma membrane (FVD PM ) was determined as described above, except that an organelle marker was not required. In a single confocal slice, the PM is a line for middle cell slices. By projecting this over the Z-axis, we obtained the membrane upper and lower limit, and the volume of this section. By selecting almost all the PM in a single cell, we attempted to prevent bias due to fluorescence variations over the entire membrane. By measuring the fluorescence in the membrane (at least two confocal slices) and dividing it by its volume, we determined the concentration of protein (YFP) in the PM. By measuring its concentration, we did not need to extend the quantification to the upper and lower (adhered) PM, which is difficult due to reduced contrast. Since we were interested in analysing GAP-43 distribution between organelles, and taken into consideration that the absolute concentration (FVD) at each compartment depends on protein expression and organelle size, we normalized the FVD of each organelle by the sum of the FVD of all organelles, to obtain its fractional concentration, according to: where i, j and k refer to different organelles (i.e. TGN, RE and PM). We decided to normalize using this parameter since it is independent of organelle size and protein expression ( Figure S1 ).
In the text, we suppress the superscript YFP for simplicity, since fractional concentration was measured only for GAP-43-YFP fusion constructs. CHO-K1 cells were transfected at − 8 h with plasmids encoding GPI-YFP, incubated with CHX and treated as described in Figure 4A of the main text. The graph shows the frequency (%) of different phenotypes of subcellular distribution of GPI-YFP. Note that after 7 h at 37 • C, GPI-YFP is not significantly transported to the plasma membrane, as reported previously [5] . Values are means+ − S.E.M. from two independent experiments, n > 150 for each time condition. full , which demonstrates that these proteins were incorporated into the same vesicular carriers at the TGN level. Second row: tannic acid treatment does not affect the Golgi complex structure. To discount an effect of tannic acid on Golgi complex structure, GalNac-T-CFP-expressing CHO-K1 cells were treated with or without tannic acid as indicated in (A) and cells were analysed by live cell confocal microscopy. The fluorescent signal of CFP was pseudocoloured red. Cell boundaries (white lines) are indicated. Scale bars, 5 μm. Values are means + − S.E.M. from three independent experiments; n > 150 for each time condition. Note that BFA has no appreciable effect on the transport of newly synthesized N13 GAP-43 from Golgi complex to PM. However, the transport of newly synthesized GPI-YFP (control protein) to PM is drastically inhibited upon treatment with BFA, as previously reported by our laboratory in the same cell line [6] .
